Savara announces participation in the leerink global healthcare conference

Langhorne, pa.--(business wire)--savara inc. (nasdaq: svra) (the company), a clinical stage biopharmaceutical company focused on rare respiratory diseases, today announced that members of its management team will attend the leerink global healthcare conference and participate in a fireside chat on tuesday, march 11th, 10:40am et/7:40am pt. the live webcast and subsequent replay will be available on the “events & presentations” section of the company's corporate website at https://savaraphar.
SVRA Ratings Summary
SVRA Quant Ranking